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Abstract The reversible phosphorylation of serine and threo-
nine residues N-terminal to proline (pSer/Thr^Pro) is an
important signaling mechanism in the cell. The pSer/Thr^Pro
moiety exists in the two distinct cis and trans conformations,
whose conversion is catalyzed by the peptidyl^prolyl isomerase
(PPIase) Pin1. Among others, Pin1 binds to the phosphorylated
C-terminal domain (CTD) of the largest subunit of the RNA
polymerase II, but the biochemical and functional relevance of
this interaction is unknown. Here we confirm that the CTD
phosphatase Fcp1 can suppress a Pin1 mutation in yeast.
Furthermore, this genetic interaction requires the phosphatase
domain as well as the BRCT domain of Fcp1, suggesting a
critical role of the Fcp1 localization. Based on these observa-
tions, we developed a new in vitro assay to analyze the CTD
dephosphorylation by Fcp1 that uses only recombinant proteins
and mimics the in vivo situation. This assay allows us to present
strong evidence that Pin1 is able to stimulate CTD dephos-
phorylation by Fcp1 in vitro, and that this stimulation depends
on Pin1’s PPIase activity. Finally, Pin1 significantly increased
the dephosphorylation of the CTD on the Ser5^Pro motif, but
not on Ser2^Pro in yeast, which can be explained with Pin1’s
substrate specificity. Together, our results indicate a new role
for Pin1 in the regulation of CTD phosphorylation and present
a further example for prolyl isomerization-dependent protein
dephosphorylation. ß 2002 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
In contrast to most other peptide bonds, peptidyl^prolyl
bonds can exist in the two distinct cis and trans conformations
in peptides and in proteins [1^3]. These two conformations
can be converted into each other, a reaction that is catalyzed
by peptidyl^prolyl isomerases (PPIases) as originally described
by Fischer and coworkers [4,5]. There are two extensively
characterized families of conventional PPIases, cyclophilins
and FKBPs. Recently, a third family of PPIases has been
identi¢ed, which can be divided into subfamilies based on
their substrate speci¢city: the parvulin-type and the Pin1-type
PPIases [6,7]. The PPIases are ubiquitous enzymes and have
been shown to be involved in protein folding, protein trans-
location through biological membranes, and signal transduc-
tion [1,2,8^12].
The highly conserved Pin1-type PPIases are the only
PPIases shown to be essential in HeLa cells and in budding
yeast [11,13]. Pin1 and its homologues from other organisms,
like Saccharomyces cerevisiae Ess1/Ptf1 [13,14], Drosophila
Dodo [15], Neurospora crassa Ssp1 [2], and others, consist
of an NH2-terminal WW domain and a COOH-terminal
PPIase domain. WW domains, which are characterized by
two invariant tryptophans, are present in a variety of signal-
ing and regulatory proteins and were originally identi¢ed as
protein interaction modules that bind to proline rich regions
of their targets [16,17]. The WW domain of Pin1, however,
has recently been shown to function as a phosphoprotein-
binding module that binds to speci¢c phosphoserine^ and
phosphothreonine^proline (pSer/Thr^Pro) motifs [18]. Ser/
Thr^Pro motifs are targets for proline-directed kinases, and
the activity of these kinases is thought to create the binding
sites for the WW domain of Pin1 [18]. The PPIase domain of
the Pin1-type proteins, which shows some homology to par-
vulin from Escherichia coli [19] and its human homologue
Par14 [20,21], exhibits a very distinct substrate speci¢city. In
contrast to parvulin-type PPIases, these proteins speci¢cally
isomerize only phosphorylated Ser/Thr^Pro bonds, but not
their unphosphorylated counterparts [2,22]. In addition, Pin1
has been shown to inhibit Cdc25c activity and to restore the
function of phosphorylated tau, a protein involved in Alz-
heimer’s disease [23,24]. Recently, Pin1 homologues from dif-
ferent plant species have been described [6,7,25]. These pro-
teins do not have an amino-terminal WW domain, but their
PPIase domain shows the same substrate speci¢city as other
Pin1-type proteins [7,25]. Thus, the existence and the biolog-
ical function of phosphorylation-speci¢c PPIases are highly
conserved throughout eukaryotic cells.
Until recently, the only enzymes known to be able to dis-
tinguish between the cis and the trans peptidyl^prolyl bond
were proteases like chymotrypsin A or subtilisin [1]. These
proteases are trans-speci¢c, cleaving their substrate only if
the preceding Xaa^Pro bond is in the trans conformation
[1]. New reports, however, have shown that the serine/threo-
nine phosphatase PP2A is also conformation-speci¢c and ef-
fectively dephosphorylates only the trans pSer/Thr^Pro isomer
[12]. In addition, Pin1 is able to accelerate the dephosphory-
lation of Cdc25c and tau by PP2A [12]. Regarding these re-
sults, the phosphorylation-speci¢c prolyl isomerization cata-
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lyzed by Pin1 appears to play an important regulatory role in
the dephosphorylation of proteins.
One of the proteins that is able to suppress the lethal phe-
notype of yeast strains with a temperature-sensitive mutation
in the yeast Pin1 homologue Ess1/Ptf1 is the phosphatase
Fcp1 [26]. Fcp1 is a speci¢c phosphatase for the C-terminal
domain (CTD) of the largest subunit of the RNA polymerase
II (RNAP II), Rpb1, and is the only CTD phosphatase
known today [27^30]. Fcp1 has been shown to be essential
in yeast [31], is needed for global transcription of protein
genes [31] and is required for the recycling of RNAP II [30].
Interestingly, an interaction between Pin1 and the phos-
phorylated form of the CTD has been described by di¡erent
groups [32,33]. The CTD consists of a seven-amino acid motif
with the consensus sequence Tyr1Ser2Pro3Thr4Ser5Pro6Ser7,
which is repeated 52 times in humans and 26^27 times in yeast
(reviewed in [34]). It is essential for cell viability and plays an
important role in the coordination of the various enzymatic
steps involved in mRNA formation [35]. The CTD is subject
to a complex regulatory mechanism based on various phos-
phorylations [36]. In vivo, two main forms of RNAP II that
di¡er in their CTD status have been characterized. The IIA
form is not phosphorylated on the CTD, is competent to bind
to basal promoters of eukaryotic genes and preferentially en-
ters the initiation complex. Shortly after initiation the IIA
form is converted into the IIO form by extensive phosphory-
lation of the CTD on Ser2 and Ser5 of the consensus hepta-
peptide by proline-directed kinases [36,37]. RNAP IIO is
found in elongation complexes as well as in pre-mRNA pro-
cessing events like 5P capping, polyadenylation, and splicing
[37]. Furthermore, di¡erent phosphorylation stages in Ser2 and
Ser5 of the heptapeptide repeat of the CTD seem to occur
during the transcriptional process, suggesting the involvement
of multiple kinases and phosphatases to modify the CTD [38].
Upon synthesis of a complete mRNA, the CTD must be de-
phosphorylated, presumably by Fcp1, in order to initiate a new
cycle of transcription. However, it has not been shown whether
Pin1 a¡ects the catalytic activity of Fcp1 towards the CTD.
Here we show that both the phosphatase domain as well as
the BRCT domain of the CTD phosphatase Fcp1 are required
to suppress the lethal phenotype of the yeast Pin1 mutant.
Based on these observations we designed a new and sensitive
in vitro assay that uses only recombinant proteins to analyze
the CTD dephosphorylation by Fcp1. Using this assay, we
show that Pin1 accelerates the dephosphorylation of the
CTD by Fcp1 and that this e¡ect depends on Pin1’s PPIase
activity. These results are supported by Western blot analysis
of lysates from yeast cultures with phospho-speci¢c CTD anti-
bodies, which provide the ¢rst in vivo evidence that the CTD
dephosphorylation is enhanced by overexpression of Pin1 in
yeast cells. Our experiments suggest that Fcp1 is a conforma-
tion-speci¢c phosphatase, and thus provide a further example
for the use of phosphorylation-speci¢c peptidyl^prolyl cis/
trans isomerization as a regulatory mechanism in the dephos-
phorylation of proteins.
2. Materials and methods
2.1. Expression of yFcp1 and its mutants in the S. cerevisiae strain
YPM2
A DNA fragment encoding the full length Fcp1 protein was gen-
erated by PCR using genomic yeast DNA and the primers Fcp1for
(5P-GAGA GGATCCT ATG ACC ACA CAA ATA AGG TCT) and
Fcp1rev (5P-GAGA CTCGAG AAGCTT CTA ATC ATC CAG
CAT ATC CAT). The PCR product of 2.2 kb was sequenced and
cloned into the vector pBC100, which allows for the production of
HA-tagged proteins in yeast under the control of the GAL1 promoter,
as described previously [11]. The Fcp1 mutants Fcp1vNLS,
Fcp1vBRCT, and Fcp1vPP were constructed using appropriate re-
striction sites within the DNA sequence of Fcp1. The reading frames
of all deletion mutants were checked by DNA sequencing.
YPM2 cells were grown overnight in YAPD medium at 23‡C and
then transformed with yFcp1/pBC100 and its mutants using the PEG
method. The transformed cells were plated onto minimal medium
containing 2% glucose but lacking the amino acid leucine to select
for transformants and grown at 23‡C for 5^7 days. Colonies were
then restreaked at least two times and incubated under the same
conditions. For the spotting analysis, single yeast colonies were sus-
pended in TE bu¡er. The OD600 was adjusted to 1, a 10-fold series
dilution in TE bu¡er was made, and 5 Wl of each dilution was spotted
onto the plates. All plates were made of minimal media without leu-
cine and contained 2% glucose (no induction) or galactose (induction).
The plates were incubated for several days at 23‡C (permissive con-
ditions) or 30‡C (restrictive conditions). As controls, YPM2 cells car-
rying only the vector pBC100 were used.
The expression of all proteins in YPM2 was veri¢ed by Western
blotting using an anti-HA antibody (12CA5). YPM2 cells carrying the
di¡erent constructs were grown at 23‡C in minimal media without
leucine and a mixture of 1% glucose and 1% galactose to induce
protein expression. The cells were harvested and lysed with glass-
beads, and 50 Wg of the lysates was separated on a 7.5% SDS^
PAGE gel and blotted on a nylon membrane.
2.2. Production and puri¢cation of proteins
Human Pin1 was produced as described previously [11,12]. Fcp1
and RAP74 proteins were produced and puri¢ed as described
[43,48]. The plasmid encoding GST-CTD was a gift from Y.J.
Wang. The protein was expressed in E. coli BL21 and puri¢ed as
described previously [41,42].
2.3. Dephosphorylation of GST-CTD in vitro
Puri¢ed GST-CTD was phosphorylated with [Q-32P]ATP and the
kinase cdc2. In general, 25 Wg GST-CTD was phosphorylated by 40
U cdc2 (NEB) overnight at room temperature in kination bu¡er (100
mM KCl, 10 mM MgCl2, 37.5 mM Tris^HCl pH 8.0, 50 WM ATP).
GST-CTD(32P) was puri¢ed using a PD10 column (Amersham Phar-
marcia) equilibrated with Fcp1 reaction bu¡er [31]. Fractions that
contained GST-CTD(32P) but no [Q-32P]ATP were stored at 380‡C
until use in a dephosphorylation assay.
For the dephosphorylation assay on glutathione beads (Sigma),
puri¢ed GST-CTD(32P), GST-RAP74(648^735) or GST were preincu-
bated with glutathione beads in dephosphorylation bu¡er for 1 h at
4‡C. The beads were washed, and, if applicable, additional proteins
like Pin1 or its mutants were added and preincubated for another 15
min. Finally, the assay was started by the addition of His10-yFcp1. At
each time point the reaction was mixed, 10 Wl aliquots were removed
and directly added to SDS^PAGE loading bu¡er to stop the reaction.
All samples were kept on dry ice and, upon completion of the time
course, directly loaded onto 15% SDS^PAGE gels for analysis. GST-
CTD(32P) and the released 32P from the phosphatase reaction, which
runs with the loading dye front, were visualized with X-ray ¢lm. The
¢lms were scanned and analyzed using the NIH image software.
2.4. Dephosphorylation of the CTD in vivo
The S. cerevisiae strain YPM2 was transformed with pBC100-based
constructs that allow for a galactose-induced expression of HA-tagged
full length Pin1, the WW domain and the PPIase domain, as described
before [12]. The expression of all proteins upon galactose induction
was veri¢ed by Western blotting. Liquid cultures of YPM2 containing
the various expression constructs or the empty vector pBC100 were
grown overnight at room temperature in minimal medium without
leucine and a glucose/galactose mixture as carbon source. The zero
time point sample was withdrawn at an OD600 of 0.8, and the remain-
ing culture was quickly adjusted to 37‡C as described [39]. The yeast
cultures were incubated at 37‡C and samples were withdrawn at the
indicated time points. All culture samples were immediately centri-
fuged, washed once with ice-cold H2O, and frozen in liquid nitrogen.
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The yeast pellets were resuspended in lysis bu¡er as described by
Patturajan et al. [40] and adjusted to the same OD600. SDS^PAGE
loading bu¡er and glassbeads (Sigma) were added, and the yeast cells
were lysed as described [40]. After recovering the yeast suspension and
boiling for 10 min, 15 Wl of the supernatant was loaded onto denatur-
ing 7.5% acrylamide gels. The gels were blotted and the phosphory-
lation status of the CTD was analyzed using the phospho-speci¢c
antibodies H5 and H14 [40]. Coomassie staining of the blot and using
the anti-tubulin antibody YOL1/34 (Abcam) veri¢ed the loading of
equal amounts of yeast lysates on the acrylamide gels.
3. Results and discussion
3.1. Both the phosphatase domain and the BRCT domain are
required for Fcp1 to rescue an Ess1/Ptf1 mutant in yeast
Fcp1 overexpression has been shown to rescue the lethal
phenotype of various temperature-sensitive mutations in
Ess1/Ptf1 at the restrictive temperature [26]. However, it is
not known whether the di¡erent domains of Fcp1, namely
Fig. 1. The phosphatase and the BRCT domain of Fcp1 are required to functional rescue the Ess1/Ptf1 mutation in the yeast strain YPM2. A:
Scheme of full length and various deletion mutants of Fcp1. B: Expression of Fcp1 and its deletion mutants in the yeast strain YPM2. YPM2
cells transformed with pBC100-based constructs of the full length and the mutated proteins were grown in glucose/galactose media at room
temperature. Expression of HA-tagged proteins is induced under these conditions. The expressed proteins were then detected by Western blot-
ting using an anti-HA antibody. C: Functional rescue of the yeast Ess1/Ptf1 mutation by Fcp1 and its mutants. YPM2 cells transformed with
the Fcp1/pBC100, Fcp1vNLS/pBC100, Fcp1vBRCT/pBC100, and Fcp1vPP/pBC100 expression constructs were spotted in a series 10U dilution
onto agar plates. The plates were incubated at 23‡C (permissive) or 30‡C (restrictive). Growth of the cells indicates the complementation of the
YPM2 mutation. As control a strain that has only the empty vector pBC100 was used.
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the phosphatase domain and the protein-interacting BRCT
domain, are required to rescue Ess1/Ptf1 mutations in yeast.
In order to verify the biological e¡ect of Fcp1 for the Ess1/
Ptf1 temperature-sensitive mutant yeast strain YPM2, that
has been described by Hani et al. [14,39] and routinely used
in our laboratory [7,12,18], we overexpressed the wild-type
protein and di¡erent deletion mutants (Fig. 1A) at the per-
missive and the restrictive temperature. As shown in Fig. 1B,
all proteins were expressed in YPM2 and migrated at the
expected size in a SDS^PAGE gel.
YPM2 cells carrying plasmids for the expression of Fcp1
and its mutants did not show any growth e¡ect under non-
inducing conditions at the permissive temperature (Fig. 1C).
However, changing the conditions to the restrictive temper-
ature, only yeast cells expressing full length Fcp1 or
Fcp1vNLS were able to survive. Therefore, deletion of the
BRCT domain (Fcp1vBRCT) or deletion of the predicted
phosphatase domain (Fcp1vPP) impairs the rescuing e¡ect
(Fig. 1C). Both domains have been described to be essential
for Fcp1 [31]. The BRCT domain is required for the binding
of Fcp1 to the transcription machinery via RAP74 [29,43]
while the phosphatase domain is required for the catalytic
action of Fcp1 [31]. Our results suggest that besides the phos-
phatase activity the proper localization of Fcp1 at the tran-
scription machinery, mediated by the BRCT domain, is im-
portant to overcome the loss of Ess1/Ptf1.
3.2. Development of a novel in vitro assay to analyze the
dephosphorylation of the CTD of the RNAP II by Fcp1
Today, a limited number of assays to analyze the dephos-
phorylation of the CTD are available. Mainly, these assays
are based on the decreased mobility of the phosphorylated
form of RNAP II in a SDS^PAGE or in the loss of radio-
activity of 32P-labeled RNAP II [27,28,44]. These assays re-
quire the puri¢cation of su⁄cient amounts of RNAP II from
organisms like yeast, which makes the assays quite complex
and di⁄cult.
We developed an in vitro assay that uses only recombinant
proteins and mimics the in vivo situation that occurs during
the dephosphorylation of the CTD. One of the essential ele-
ments in the RNAP II complex is the interaction between
RAP74 and the BRCT domain of Fcp1. This interaction lo-
calizes Fcp1 to the RNAP II complex bringing the phosphor-
ylated CTD and Fcp1 in close proximity to each other. This
close proximity of the CTD and Fcp1 seems to be a crucial
factor for an e⁄cient CTD dephosphorylation based on our
observation that the BRCT domain of Fcp1 is required to
suppress the Ess1/Ptf1 mutation in YPM2. Furthermore,
Fcp1 gets activated by this interaction. As has been published
recently [43,45], the very C-terminus of RAP74 is already
su⁄cient for the interaction with and activation of Fcp1. In
our assay we were able to achieve a similar situation by bind-
ing the di¡erent reaction partners to glutathione beads. After
Fig. 2. Development of the novel in vitro matrix-based CTD dephosphorylation assay with Fcp1. A: Schematic presentation of the matrix-
based CTD dephosphorylation assay using glutathione beads, 32P-labeled GST-CTD, GST-RAP74c, and His10-yFcp1. B: GST-RAP74c greatly
enhances His10-yFcp1 activity towards GST-CTD(32P) in the matrix-based assay. GST-CTD(32P) and GST or GST-RAP74c were coupled to
glutathione beads. Free RAP74c was added for one experiment, and the reaction was initiated by adding 500 nM His10-yFcp1. The reactions
were incubated at room temperature and aliquots were removed at the indicated time points. The released 32P was visualized by autoradiogra-
phy. C: Quanti¢cation of the released 32P. The signal of the released 32P was quanti¢ed by analyzing the scanned ¢lms with the NIH image
software. Arbitrary units (AU) were calculated by dividing the values for a given time point by the value for the 5 min time point of the GST
control.
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coupling GST-CTD(32P) and GST-RAP74(648^735) [43] to
the beads, added Fcp1 binds to RAP74(648^735), which local-
izes Fcp1 close to CTD(32P) and initiates the dephosphoryla-
tion (Fig. 2A).
Results of experiments using this assay are shown in Fig.
2B and quanti¢ed in Fig. 2C. Using only His10-Fcp1 and GST
as control, we detected only a weak 32P signal similar to ex-
periments where no glutathione beads were included in the
assay (data not shown). When we added RAP74c to the de-
phosphorylation reaction, we detected a prominent increase in
the 32P signal (Fig. 2B,C), con¢rming an activation of FCP1
by RAP74c [43]. However, when we used GST-RAP74c the
release of 32P increased dramatically (Fig. 3B). Quanti¢cation
of the 32P signals reveals that, after 60 min incubation, the
addition of free RAP74c or GST-RAP74c results in a 2- or
more than 4-fold increase in the Fcp1 phosphatase activity,
respectively (Fig. 2C). When we determined the initial rates of
the Fcp1 reaction, the addition of free RAP74c results in a 4-
fold increase (from 0.04 min31 to 0.12 min31). Using GST-
RAP74c in the assay, however, increased the initial rate more
than 10 times when compared with the control reaction (from
0.03 min31 to 0.37 min31). These results suggest that RAP74
had a dual e¡ect, namely activation and targeting of Fcp1 to
promote e⁄cient dephosphorylation of the CTD. Further-
more, the strong activation of Fcp1 by GST-RAP74c indi-
cates that our in vitro assay indeed seems to mimic the in
vivo situation correctly.
3.3. Pin1 accelerates the dephosphorylation of phosphorylated
CTD by Fcp1 in vitro
Based on the genetic interaction between Pin1 and Fcp1 we
looked for a biochemical relationship between the two pro-
teins. We investigated if the addition of Pin1 to the Fcp1
activity assay somehow a¡ects the dephosphorylation of the
CTD. Comparing experiments with and without Pin1 we ob-
served a signi¢cant increase in the CTD dephosphorylation
when Pin1 was present (Fig. 3A). Quanti¢cation of ¢ve inde-
pendent experiments reveals that up to 20 min the control and
the Pin1 reactions are nearly similar (Fig. 3B). However, after
30 min the signals become increasingly di¡erent, showing that
Pin1 accelerates the CTD dephosphorylation by Fcp1 (Fig.
3B). It seems that Pin1 progressively enhances the dephos-
phorylation. The di¡erences between the reactions with and
without Pin1 become more pronounced at later time points,
being highest at 60 min when we stopped the reaction. Here,
Pin1 enhances the dephosphorylation about 2-fold (Fig. 3B).
Although the e¡ect of Pin1 on dephosphorylation of CTD by
FCP1 is not dramatic, it is signi¢cant because it has previ-
ously been demonstrated that the e¡ect of Pin1 on dephos-
phorylation by PP2A is about 2^3-fold [12]. Also, Pin1’s e¡ect
on Cdc25c activity is about 1.2^1.5-fold [46].
To examine whether the WW domain or the PPIase domain
is required for Pin1 to a¡ect CTD dephosphorylation, we
added di¡erent truncation mutants of Pin1 to the reaction.
As shown in Fig. 4, the addition of 1 WM WW domain did
not increase the CTD dephosphorylation, whereas the PPIase
domain alone was able to stimulate the reaction (Fig. 4).
When we used a concentration of 1 WM PPIase domain, the
e¡ect was obvious but signi¢cantly lower than what we ob-
served with 1 WM Pin1 (Fig. 4). However, after we increased
the concentration of the PPIase domain to 4 WM, a signal
similar to the reaction with 1 WM Pin1 was observed (Fig.
4). These results indicate that the PPIase activity of Pin1 is
also su⁄cient to promote an e⁄cient dephosphorylation of
the CTD by Fcp1, provided the concentration of the PPIase
domain in the assay is high. This is consistent with the pre-
vious report that the PPIase domain alone can accelerate the
dephosphorylation by PP2A [12]. Therefore, the WW domain
of the full length protein is probably required to target Pin1 to
the phosphorylated CTD. The presented data are an addition-
al example that the PPIase domain alone is required and
su⁄cient to ful¢ll Pin1’s function.
Fig. 3. Pin1 accelerates the dephosphorylation of GST-CTD(32P).
GST-CTD(32P) and GST-RAP74c were coupled to glutathione
beads. 1 WM Pin1 was added to the reaction and the dephosphory-
lation reactions were started with 500 nM His10-yFcp1. The reac-
tions were incubated at 10‡C and aliquots were removed at the indi-
cated time points. A: Autoradiograph and (B) quanti¢cation (n = 5)
of dephosphorylation reactions with 1 WM Pin1.
Fig. 4. The PPIase activity of Pin1 is su⁄cient to stimulate the de-
phosphorylation of GST-CTD(32P). Pin1, the WW domain or the
PPIase domain were added to the CTD dephosphorylation reaction
described in Fig. 2. A: Autoradiograph and (B) quanti¢cation
(n = 5) of the 60 min time point of the dephosphorylation reactions.
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3.4. Pin1 in£uences the dephosphorylation of the CTD in vivo
In order to con¢rm the signi¢cance of Pin1 in the Fcp1
dephosphorylation reaction, we ectopically expressed Pin1 to
replace yeast Ess1/Ptf1 to examine whether it somehow in£u-
ences the phosphorylation status of the CTD in vivo.
We transformed YPM2 with plasmids that enable the ga-
lactose-induced expression of Pin1 [12]. Cultures growing in
minimal medium with Glu/Gal were subjected to a 37‡C heat
shock to inactivate the endogenous heat-sensitive Ess1/Ptf1
[39]. Aliquots of the cultures were withdrawn at the indicated
time points and analyzed for CTD phosphorylation by West-
ern blotting (Fig. 5). We used the two antibodies H5 and H14,
which speci¢cally recognize either the pSer2^Pro or the pSer5^
Pro epitope of the CTD, respectively [40]. Equal loading of
the gels was con¢rmed by Coomassie staining of the blot (not
shown) and by detecting yeast tubulin with the monoclonal
antibody YOL1/34 (Fig. 5).
Our results clearly show that the expression of Pin1 was
able to in£uence the phosphorylation state of the CTD. The
e¡ects, however, were di¡erent for Ser2 and Ser5 of the con-
sensus sequence Tyr1Ser2Pro3Thr4Ser5Pro6Ser7. As compared
with the control experiment, the overall phosphorylation of
Ser2 was not changed signi¢cantly when Pin1 or its mutants
were expressed, as detected by the H5 antibody (Fig. 5A).
However, the analysis of the Ser5 phosphorylation with the
speci¢c antibody H14 showed a di¡erent result (Fig. 5B). The
phosphorylation status of the CTD on Ser5 decreased signi¢-
cantly after 15 min growth at 37‡C when Pin1 was expressed.
The pSer5 signal was even weaker after 30 min growth at the
higher temperature. These results indicate that the Pin1 e¡ect
on the dephosphorylation of the CTD is di¡erent for Ser2 and
Ser5 phosphorylation. While the phosphorylation of Ser2 is
not in£uenced, overexpression of Pin1 results in a decreased
level of the pSer5 epitope in vivo. This di¡erence between
pSer2 and pSer5 is consistent and can be explained with a
recently published crystal structure of Pin1 and the phosphor-
ylated form of the CTD heptapeptide [47]. The study shows
that pSer5 is required for the interaction with the WW domain
of Pin1, whereas pSer2 is not. It is known that the binding
sites of Pin1 in Cdc25c and tau are also isomerized by Pin1
[12]. In analogy, this suggests that Pin1 preferentially targets
the pSer5^Pro bond of the CTD consensus and that Pin1
e¡ects would be seen mainly at that position.
In summary, we have found that both the phosphatase
domain and the BRCT domain of Fcp1 are required for its
ability to rescue the Ess1 lethal phenotype. Based on this
observation and other previous results, we developed a new
in vitro assay to analyze the CTD dephosphorylation by Fcp1
that uses only recombinant proteins and mimics the in vivo
situation of the CTD complex formation during the dephos-
phorylation of the CTD. This assay allows us to demonstrate
for the ¢rst time that Pin1 accelerates dephosphorylation of
the CTD by FCP1 in vitro and this e¡ect is mediated by the
PPIase domain. Finally, Pin1 also increases the dephosphor-
ylation of the CTD preferentially on the Ser5^Pro motif in
yeast. These results demonstrate a new role for Pin1 in the
regulation of CTD dephosphorylation.
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